Polatuzumab Vedotin: First Global Approval (vol 79, pg 1467, 2019)

被引：1

作者：

Deeks, Emma D. ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand

来源：

关键词：

D O I：

10.1007/s40265-019-01214-w

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1829 / 1829

页数：1

共 50 条

[21] Olmutinib: First Global Approval (vol 76, pg 1153, 2016)
Kim, Esther S.
[J]. DRUGS, 2016, 76 (12) : 1233 - 1233
[22] Durvalumab: First Global Approval (vol 77, pg 1369, 2017)
Syed, Yahiya Y.
[J]. DRUGS, 2017, 77 (16) : 1817 - 1817
[23] Fremanezumab: First Global Approval (vol 78, pg 1829, 2018)
Hoy, Sheridan M.
[J]. DRUGS, 2019, 79 (05) : 585 - 585
[24] Acotiamide: First Global Approval (vol 73, pg 1377, 2013)
Nowlan, Mary L.
Scott, Lesley J.
[J]. DRUGS, 2014, 74 (09) : 1059 - 1059
[25] Ibalizumab: First Global Approval(vol 78, pg 781, 2018)
Markham, Anthony
[J]. DRUGS, 2018, 78 (08) : 859 - 859
[26] Strongly interacting photons in a nonlinear cavity (vol 79, pg 1467, 1997)
Imamoglu, A
Schmidt, H
Woods, G
Deutsch, M
[J]. PHYSICAL REVIEW LETTERS, 1998, 81 (13) : 2836 - 2836
[27] Moxetumomab Pasudotox: First Global Approval (vol 78, pg 1763, 2018)
Dhillon, Sohita
[J]. DRUGS, 2019, 79 (01) : 105 - 105
[28] Andexanet Alfa: First Global Approval (vol 78, pg 1049, 2018)
Heo, Young-A
[J]. DRUGS, 2018, 78 (12) : 1285 - 1285
[29] Winterlong (vol 29, pg 79, 2019)
McGill, H.
[J]. SIGHT AND SOUND, 2019, 29 (06): : 95 - 95
[30] The percentage cube (vol 79, pg 20, 2019)
Zhang, Yiqun
Ordonez, Carlos
Garcia-Garcia, Javier
Bellatreche, Ladjel
Carrillo, Humberto
[J]. INFORMATION SYSTEMS, 2019, 83 : 217 - 217